|
|
Post by JHam on Mar 2, 2016 11:48:28 GMT
|
|
|
|
Post by hansgruber on Mar 2, 2016 12:42:40 GMT
Nice. When do you guys anticipate some trial results to be released? I thought some mmeting this spring there could be a possibility?
|
|
|
|
Post by JHam on Mar 2, 2016 13:08:46 GMT
Nice. When do you guys anticipate some trial results to be released? I thought some mmeting this spring there could be a possibility? In the PR it says "by" 3Q16. So I guess we should anticipate before July for the extension study. |
|
|
|
Post by harleyquinn on Mar 2, 2016 15:26:20 GMT
Indeed, wish market would react. |
|
|
|
Post by harleyquinn on Mar 2, 2016 15:54:31 GMT
Any thoughts why this is down when the rest of the sector is up?
|
|
|
|
Post by jckrdu on Mar 2, 2016 16:21:26 GMT
Any thoughts why this is down when the rest of the sector is up? Most people are reading the PR stating "by 3rd Qtr" to mean by the end of the 3rd quarter, which is how I'm reading it. So, guidance is results by end of Sept 2016, and people are selling that news.... IMO.
|
|
|
|
Post by RLC on Mar 2, 2016 16:23:09 GMT
Any thoughts why this is down when the rest of the sector is up? I wish I had an answer on this one. FWIW, I saw today's news as great and decided to add another chunk of shares. With the following verbiage, a firm stake is now in the ground: "The Company expects to report consolidated data from the OMS-I100 and extension studies by Q3 2016" |
|
|
|
Post by jckrdu on Mar 2, 2016 16:28:38 GMT
Any thoughts why this is down when the rest of the sector is up? I wish I had an answer on this one. FWIW, I saw today's news as great and decided to add another chunk of shares. With the following verbiage, a firm stake is now in the ground: "The Company expects to report consolidated data from the OMS-I100 and extension studies by Q3 2016"Good luck RLC.
I'm watching ONCS. Want to see the latest financials next week before I buy.
|
|
|
|
Post by hansgruber on Mar 2, 2016 16:38:52 GMT
Duh. i didn't read that first paragraph too thoroughly. Thanks...
|
|
|
|
Post by RLC on Mar 2, 2016 16:43:32 GMT
Any thoughts why this is down when the rest of the sector is up? Most people are reading the PR stating "by 3rd Qtr" to mean by the end of the 3rd quarter, which is how I'm reading it. So, guidance is results by end of Sept 2016, and people are selling that news.... IMO.
As far as I know, people didn't really know when to expect data to be released. With enrollment now completed and firm guidance for Q3 2016 given by the company, I can't really find a way to view this negatively (just my opinion). And as for the market reaction... I would almost call it a non reaction as the volume hasn't even reached 20,000 shares yet and the PPS has been pretty much flat all day. |
|
|
|
Post by jckrdu on Mar 2, 2016 16:55:58 GMT
Most people are reading the PR stating "by 3rd Qtr" to mean by the end of the 3rd quarter, which is how I'm reading it. So, guidance is results by end of Sept 2016, and people are selling that news.... IMO.
As far as I know, people didn't really know when to expect data to be released. With enrollment now completed and firm guidance for Q3 2016 given by the company, I can't really find a way to view this negatively (just my opinion). And as for the market reaction... I would almost call it a non reaction as the volume hasn't even reached 20,000 shares yet and the PPS has been pretty much flat all day. I'm hoping/expecting ONCS to release some type of data (biomarker data perhaps) at ASCO in early June. I expect a little bit of run-up prior to ASCO.
Just want to wait to see their cash position next week, as ASCO is still several months away, and we could see a negative reaction if the cash position doesn't paint a positive picture.
|
|
|
|
Post by alcalde on Mar 2, 2016 17:04:51 GMT
At least we are slated to get several data read outs within the next 6 months: Combo trial interim data, TNBC trial interim data, extension study final data, Heat collaboration data. Did I miss any?
|
|
